Its pathological expression in lung cancer and most other malignancies is due to chromosomal translocations that lead to the formation of an ALK-derived oncogenic fusion proteins, which are overexpressed and constitutively activated in cancer cells. The gene discussed is ALK; the disease is lung cancer.